EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Nano‐Flow Cytometry of Single Extracellular Vesicles Reveals Subpopulation Differences Across Cell Types and Pharmacological Perturbations

Nathalie Nevo iD, Alix Zhou, Nicolas Ansart, Lea Cohen-Attali iD, Eric Rubinstein iD, Coralie Guérin iD, Lorena Martin-Jaular iD, Clotilde Théry iD

Journal of Extracellular Vesicles · 2026-04 · 15 (4)

DOI: 10.1002/jev2.70271 ↗

At a glance

Journal article in Journal of Extracellular Vesicles, published online on 2026-04-14. Written by Nathalie Nevo and 7 co-authors. Institution: INSERM U932, PSL Research university, Institut Curie Research center, Paris, France. Major MEDLINE topics: Flow Cytometry, Extracellular Vesicles. Cited 6 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: INSERM, CNRS, Institut Curie, SIRIC Curie/INCa-DGOS-Inserm-ITMO Cancer_18000, PSL research University, ITMO Cancer of Aviesan 2021-2030; Program France 2030 launched by the French Government, Association pour la Recherche sur le Cancer.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Extracellular vesicles (EVs) are lipid bilayer‐enclosed particles released by most cell types, which can transfer signals and cargoes between cells. EVs released by a single donor cell source are increasingly recognised as extremely heterogeneous in terms of size, intracellular origin, and cargo composition. Analysing large numbers of EVs at the single vesicle level is therefore the only way to truly decipher their heterogeneity. Here, we developed a reliable pipeline of single EV analysis using a nanoparticle‐dedicated flow cytometer (Flow NanoAnalyzer, nanofcm), which detects particles smaller than 200 nm in diameter, without the need for vesicle pre‐immobilisation or fluorescent labels. We show that titrating each antibody, eliminating unbound antibodies and using EVs devoid of the analysed markers as negative controls are required to reliably quantify the proportion of EVs bearing none or any combination of two markers. We thus observed, depending on the cell source (human cell lines MDA‐MB‐231, HeLa, A549), variable proportions of EVs bearing none of the CD9, CD81 and CD63 tetraspanins often used to define EVs, and of single‐ and double‐positive EVs for each of these markers. For MDA‐MB‐231, we also observed CD29 (ITGB1) as a protein detected as frequently on EVs as CD9, while other transmembrane proteins (CD44, CD98), and a ganglioside (SSEA‐4) were detected in a small proportion of EVs, and mostly of relatively large size. Finally, we used this pipeline to uncover differential effects of small molecule drugs on subtypes of EVs, and showed that Homosalate increased the proportion of CD9+/CD63+ EVs while two other drugs, Dipivefrin hydrochloride and Metaraminol bitartrate, instead increased the proportion of CD9‐/CD63+ EVs. Overall, nano‐flow cytometry allows us to reliably quantify proportions of EV subpopulations suggested by bulk analyses of EV markers, at single EV resolution.

Subjects

MeSH terms (MEDLINE)

Flow CytometryExtracellular VesiclesHumansTetraspanin 30HeLa CellsTetraspanin 29Cell Line, TumorBiomarkersNanoparticles

Substances

Tetraspanin 30Tetraspanin 29Biomarkers

Authors and institutions

  • INSERM U932, PSL Research university, Institut Curie Research center, Paris, France.
  • CurieCoreTech ExtracellularVesicles, Institut Curie Research center, Paris, France.
  • CurieCoreTech Cytometry, Institut Curie Research center, Paris, France.
  • Inserm, CNRS, Sorbonne Université Centre d'Immunologie et des Maladies Infectieuses, Paris, France.

ORCID profiles: Nathalie Nevo, Lea Cohen-Attali, Eric Rubinstein, Coralie Guérin, Lorena Martin-Jaular, Clotilde Théry

Funding

  • INSERM, CNRS, Institut Curie, SIRIC Curie/INCa-DGOS-Inserm-ITMO Cancer_18000, PSL research University
  • ITMO Cancer of Aviesan 2021-2030; Program France 2030 launched by the French Government
  • Association pour la Recherche sur le Cancer
  • Fondation Chercher et Trouver
  • Agence Nationale de la Recherche
  • Institut National Du Cancer

Cite

APA

Nevo, N., Zhou, A., Ansart, N., Cohen-Attali, L., Rubinstein, E., Guérin, C., Martin-Jaular, L., & Théry, C. (2026). Nano‐Flow Cytometry of Single Extracellular Vesicles Reveals Subpopulation Differences Across Cell Types and Pharmacological Perturbations. Journal of Extracellular Vesicles, 15(4). https://doi.org/10.1002/jev2.70271

Vancouver

Nevo N, Zhou A, Ansart N, Cohen-Attali L, Rubinstein E, Guérin C, et al. Nano‐Flow Cytometry of Single Extracellular Vesicles Reveals Subpopulation Differences Across Cell Types and Pharmacological Perturbations. Journal of Extracellular Vesicles. 2026;15(4). doi:10.1002/jev2.70271

BibTeX
@article{Nevo2026,
  author = {Nevo, Nathalie and Zhou, Alix and Ansart, Nicolas and Cohen-Attali, Lea and Rubinstein, Eric and Guérin, Coralie and Martin-Jaular, Lorena and Théry, Clotilde},
  title = {Nano‐Flow Cytometry of Single Extracellular Vesicles Reveals Subpopulation Differences Across Cell Types and Pharmacological Perturbations},
  journal = {Journal of Extracellular Vesicles},
  year = {2026},
  volume = {15},
  number = {4},
  doi = {10.1002/jev2.70271}
}
Start for free →